RECRUITING

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Official Title

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Quick Facts

Study Start:2015-07-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02677961

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
  2. * Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate.
  1. * Prisoners are excluded from participation in the Registry.

Contacts and Locations

Study Contact

Erin Fetzer
CONTACT
erin.fetzer@osumc.edu
David A Liebner, MD
CONTACT
(614) 293-2886
David.Liebner@osumc.edu

Principal Investigator

David A Liebner, MD
PRINCIPAL_INVESTIGATOR
Ohio State University

Study Locations (Sites)

Ohio State University
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Ohio State University Comprehensive Cancer Center

  • David A Liebner, MD, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-07-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2015-07-01
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • sarcoma
  • registry

Additional Relevant MeSH Terms

  • Neoplasms, Connective and Soft Tissue
  • Bone Neoplasms